RemeGen Co. Ltd. Class A RemeGen Co. Ltd. Class A

RemeGen Co. Ltd. Class A

688331

Rank in Stocks #2476
RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces,... RemeGen Co., Ltd., a biopharmaceutical company, discovers, develops, produces, and commercializes biological drugs for the treatment of autoimmune, oncology, and ophthalmic diseases in Mainland China and the United States. The company offers Telitacicept (RC18) for the treatment of systemic lupus erythematosus (SLE) autoimmune disease, rheumatoid arthritis, and myasthenia gravis; and Disitamab Vedotin (RC48), an antibody drug conjugate for the treatment of gastric cancer, urothelial carcinoma, breast cancer, and other tumors. It also develops products in various stages, including RC-28E, a fusion protein that targets vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF); RC88, an antibody-drug conjugate (ADC) that targets mesothelin; and RC148, a bispecific antibody ADC drug that in Phase1/2 clinical studies targeting program cell death protein 1 (PD-1) and VEGF; RC278, an ADC drug for the treatment of multiple solid tumors; and RC288, a dual-antibody ADC drug for the treatment of various tumors. The company was founded in 2008 and is headquartered in Yantai, the People's Republic of China.
Share Price
$14.07
Market Cap
$7.88B
Change (1 day)
-2.90%
Change (1 year)
2.98%
Country
CN
Trade RemeGen Co. Ltd. Class A (688331)

Category

Healthcare
Dividend yield history for RemeGen Co. Ltd. Class A (688331)
RemeGen Co. Ltd. Class A (stock symbol: 688331) dividend yield (TTM) as of 2023-12-31: 0.05%
Average dividend yield, last 5 years : 0.10%
Dividend yield history for RemeGen Co. Ltd. Class A (688331) from 2018 to 2026
Dividend Yield at the end of each year (TTM)
Year Dividend Yield Change
2026 (TTM) 0.00% -100.00%
2024 0.43% 760.00%
2023 0.05% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
Dividend yields (TTM) for similar companies or competitors
Company Dividend Yield Country
0.00%
US
0.00%
US
2.17%
AU
0.00%
CH
0.00%
NL